Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring

In this webinar we will delve into the crucial role of flow cytometry in analyzing and characterizing critical quality attributes of CAR T cell products, including identity, purity, and potency, throughout the manufacturing process.

We will also explore how flow cytometry can be used to monitor cell expansion and persistence post-infusion, offering attendees a comprehensive understanding of how this powerful tool can be applied to ensure high-quality CAR T cell products.

Discover tested panels for CAR T cell characterization by flow cytometry
Explore new technologies that can further enhance the sensitivity and resolution capabilities of CAR T cell flow cytometry assays
Learn how to achieve results that are reproducible across different experiments and laboratories

Stephan Wilmes

Senior Scientist, R&D, Miltenyi Biotec

Stephan Wilmes has been working in the field of biophysics and immunology for over ten years now, with a keen interest in the clinical potential of CAR T cells. His focus on immuno-oncology, combined with the skills acquired during his time as a PhD/post-doctoral researcher, led him to his current role at Miltenyi Biotec as a team coordinator for assay development in CAR T cell therapy and CAR Detection Reagents. Prior to this position, he conducted research in the immunology lab of Dr. Ignacio Moraga-Gonzalez at Dundee, UK, where cytokine signaling in human T-cells was investigated and manipulated using protein engineering, high-throughput flow cytometry, and mass-spectrometry-based quantitative proteomics and RNAseq-based transcriptomics.